Page last updated: 2024-09-04

atazanavir sulfate and phenyl acetate

atazanavir sulfate has been researched along with phenyl acetate in 3 studies

Compound Research Comparison

Studies (atazanavir sulfate)	Trials (atazanavir sulfate)	Recent Studies (post-2010) (atazanavir sulfate)	Studies (phenyl acetate)	Trials (phenyl acetate)	Recent Studies (post-2010) (phenyl acetate)
1,102	246	590	41,232	1,558	8,330

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Chen, J; Hanna, I; Koo, P; Majumdar, T; Mendonza, A; Meyers, D; Neelakantham, S; Rebello, S; Sunkara, G; Zhu, B	1
Ma, C; Wang, J	1
Huang, YY; Li, Z; Lin, Y; Liu, R; Luo, HB; Wang, X; Zhan, CG	1

Trials

1 trial(s) available for atazanavir sulfate and phenyl acetate

Article	Year
Assessment of pharmacokinetic drug-drug interaction between pradigastat and atazanavir or probenecid. Journal of clinical pharmacology, 2016, Volume: 56, Issue:3 Topics: Acetates; Adolescent; Adult; Aminopyridines; Atazanavir Sulfate; Dose-Response Relationship, Drug; Drug Interactions; Female; Glucuronosyltransferase; Healthy Volunteers; Humans; Male; Mefenamic Acid; Middle Aged; Probenecid; Young Adult	2016

Article

Year

Assessment of pharmacokinetic drug-drug interaction between pradigastat and atazanavir or probenecid.

Journal of clinical pharmacology, 2016, Volume: 56, Issue:3

Topics: Acetates; Adolescent; Adult; Aminopyridines; Atazanavir Sulfate; Dose-Response Relationship, Drug; Drug Interactions; Female; Glucuronosyltransferase; Healthy Volunteers; Humans; Male; Mefenamic Acid; Middle Aged; Probenecid; Young Adult

2016

Other Studies

2 other study(ies) available for atazanavir sulfate and phenyl acetate

Article	Year
Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 2021, 02-23, Volume: 118, Issue:8 Topics: Acetates; Atazanavir Sulfate; Benzimidazoles; Biphenyl Compounds; Chloroquine; COVID-19 Drug Treatment; Cyclopropanes; Dipyridamole; Humans; Oxytetracycline; Pharmaceutical Preparations; Protease Inhibitors; Quinolines; SARS-CoV-2; Sulfides; Tetrazoles	2021
Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 2021, 02-23, Volume: 118, Issue:8 Topics: Acetates; Atazanavir Sulfate; Benzimidazoles; Biphenyl Compounds; Chloroquine; COVID-19 Drug Treatment; Cyclopropanes; Dipyridamole; Humans; Oxytetracycline; Protease Inhibitors; Quinolines; Reproducibility of Results; SARS-CoV-2; Sulfides; Tetrazoles	2021

Article

Year

Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors.

Proceedings of the National Academy of Sciences of the United States of America, 2021, 02-23, Volume: 118, Issue:8

Topics: Acetates; Atazanavir Sulfate; Benzimidazoles; Biphenyl Compounds; Chloroquine; COVID-19 Drug Treatment; Cyclopropanes; Dipyridamole; Humans; Oxytetracycline; Pharmaceutical Preparations; Protease Inhibitors; Quinolines; SARS-CoV-2; Sulfides; Tetrazoles

2021

Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors.

Proceedings of the National Academy of Sciences of the United States of America, 2021, 02-23, Volume: 118, Issue:8

Topics: Acetates; Atazanavir Sulfate; Benzimidazoles; Biphenyl Compounds; Chloroquine; COVID-19 Drug Treatment; Cyclopropanes; Dipyridamole; Humans; Oxytetracycline; Protease Inhibitors; Quinolines; Reproducibility of Results; SARS-CoV-2; Sulfides; Tetrazoles

2021